Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-t…
Industry Peers
Packaged Foods| Headline | Source | Time |
|---|---|---|
This week | ||
AAgriland | ||
Older | ||
IIrish Farmers Journal | ||
BBusiness Post | ||
BBusiness Post | ||
BBusiness Post | ||
Glanbia PLC (GLAPF) (H1 2026) Earnings Call Highlights: EPS Soars 30% as Optimum Nutrition ... Company raises full-year guidance to 17-20% growth despite whey cost headwinds and consumer elasticity concerns. | ||
IIrish Farmers Journal | ||
IIrish Farmers Journal | ||
Glanbia bulks up forecasts amid protein demand The Optimum Nutrition and Isopure owner now expects adjusted earnings per share to grow 17-20% on a constant-currency basis in 2026. | ||
Glanbia H1 Earnings Call Highlights Glanbia (LON:GLB) reported higher first-half revenue, earnings and profitability as demand remained strong across its Performance Nutrition, Health & Nutrition and Dairy Nutrition businesses, prompting the company to raise its full-year adjusted earnings-per-share outlook. Chief Executive Offic | ||
IIrish Independent | ||
TThe Irish Times | ||
IIrish Farmers Journal | ||
IIrish Farmers Journal | ||
IIrish Examiner | ||
AAgriland | ||
TThe Times | ||
Glanbia (ISE:GL9) Valuation Check After Mixed Share Price Performance And Premium P/E Ratio Glanbia stock: key performance snapshot Glanbia (ISE:GL9) has drawn investor attention after recent share price moves, with the stock showing a negative 1 day return of 2.36% and a mixed pattern across the past week, month and past 3 months. See our latest analysis for Glanbia. Despite the recent 2.35% one-day share price decline to €17.0, Glanbia’s 90-day share price return of 14.71% and 1-year total shareholder return of 75.78% suggest momentum has been building over a longer horizon. If... | ||
Glanbia PLC (GLAPF) Full Year 2025 Earnings Call Highlights: Navigating Growth Amidst Cost ... Glanbia PLC (GLAPF) reports steady revenue growth and strategic expansions despite facing margin pressures from rising whey costs. | ||
Looking At The Narrative For Glanbia (ISE:GL9) After Subtle Shifts In Street Targets The small move in Glanbia’s modelled fair value, from €17.71 to €17.74, reflects how recent research is gently recalibrating expectations rather than rewriting the story. With the discount rate held at 6.05% and revenue growth in the model adjusted from 2.48% to 2.89%, analysts are indicating a slightly stronger top line outlook while keeping their view of risk unchanged. Investors can monitor these kinds of gradual shifts in the Glanbia narrative as new information becomes available. Analyst... | ||
A Look At Glanbia (ISE:GL9) Valuation After Recent Share Price Strength What Glanbia’s recent share move tells you Glanbia (ISE:GL9) has recently caught investor attention, with the share price at €16.75 after a 2.1% move in the latest session, prompting a closer look at its recent performance and fundamentals. See our latest analysis for Glanbia. That 2.1% one day share price move sits within a stronger trend, with a 30 day share price return of 16.6% and a 1 year total shareholder return of 23.0%. The 5 year total shareholder return of 91.0% points to... | ||
Assessing Glanbia (ISE:GL9) Valuation: Is There Untapped Upside After a Steady Share Price Climb? Glanbia (ISE:GL9) shares have moved only slightly in recent days. However, the company’s performance over the past month paints a more dynamic picture. Investors may be eyeing the steady upward trend since the start of the year. See our latest analysis for Glanbia. After a steady grind higher since January, Glanbia has continued to attract investor attention. The company’s 30-day share price return of 4.5% builds on gains earlier in the year, while its 12-month total shareholder return of... | ||